665 Immunotherapeutic trial in men with biochemical recurrence after definitive local therapy for prostate cancer: A clinical trial in progress

• Neal Shore,
• Robert Dreicer,
• Matthew Zibelman,
• Mark N Stein,
• Ralph J Hauke,
• Russell Pachynski,
• Bethan Jones,
• Jessica Hawley,
• Charlotte Davis,
• Katie Anderson,
• Antonella Vardeu,
• Margaret A Marshall,
• Vicky Wheeler,
• Sarah Sebastian,
• Kevin Kayvan Zarrabi,
• Brian Miles,
• Jennifer Bendall

Affiliations

Neal Shore

11Carolina Urologic Research Center, Myrtle Beach, SC, USA

Robert Dreicer

Aff479 grid.27755.32000000009136933XUniversity of Virginia School of Medicine Charlottesville VA USA

Matthew Zibelman

Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA

Mark N Stein

Aff2 grid.430387.b0000000419368796Rutgers Cancer Institute of New Jersey New Brunswick NJ USA

Ralph J Hauke

6Nebraska Cancer Specialists, Omaha, NE, USA

Russell Pachynski

7Washington University School of Medicine, St Louis, MO, USA

Bethan Jones

1 School of Health and Social Wellbeing, University of the West of England, Bristol, UK

Jessica Hawley

UCLA Medical Center, Santa Monica, USA, and Department of Medicine, Division of Hospitalist Services, David Geffen School of Medicine at UCLA, Los Angeles, USA

Charlotte Davis

10Vaccitech, Didcot, Oxford, UK

Katie Anderson

1University Hospitals Sussex, Brighton, UK

Antonella Vardeu

Vaccitech Limited, Oxford, UK

Margaret A Marshall

Vaccitech Limited, Oxford, UK

Vicky Wheeler

Vaccitech Limited, Oxford, UK

Sarah Sebastian

Vaccitech Limited, Oxford, UK

Kevin Kayvan Zarrabi

6Fox Chase Cancer Center, Philadelphia, PA

Brian Miles

7Houston Methodist Urology Associates, Houston, TX, USA

Jennifer Bendall

10Vaccitech, Didcot, Oxford, UK